ARCHIVES

Agency Approves HPV Test That Detects 14 High-Risk Strains

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Impeding Reagan Budget Cuts Feared By Cancer Program Advocates; DeVita Asks Parity With NIH

February 13, 1981

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002